Skip to content
Dose Brief
Menu

Provider review

50 Stars Health review

By · Updated

Published dose-flat pricing and ongoing support, but longer plans, restricted state access and conflicting evaluation-fee wording deserve a closer look.

Not rated. This review examines published program information; it is not a firsthand treatment review.

At a glance

Semaglutide
$146/month on the monthly plan; $133/month on three months or $124/month on six months
Tirzepatide
$220/month on the monthly plan; $201/month on three months or $183/month on six months
Availability
GLP-1 product FAQ lists 44 states and Puerto Rico, not all 50 states; confirm the specific treatment and your location.
Treatment formats
Compounded semaglutide with B12 and compounded tirzepatide with B3, by injection.

An automatically renewing subscription. Longer-plan figures are monthly equivalents; confirm the upfront total. Cancel at least two days before billing.

In this review

Compare the selected plan, not just the lowest rate

The semaglutide product page (opens in a new tab) lists $146 a month on the monthly plan, $133 a month on a three-month plan and $124 a month on six months. The tirzepatide page (opens in a new tab) lists $220, $201 and $183 respectively. Both pages say prescribed dose changes do not change the price.

The lower figures belong to longer subscriptions. The public price table does not establish a complete upfront charge and collection schedule for those plans. Ask what will be charged today, when the next charge occurs and how much medication each delivery contains. That matters more than comparing a six-month equivalent with another provider's single-month bill.

The bundle includes care, shipping and supplies

The treatment FAQs say pricing includes the initial consultation, follow-up visits, ongoing support, shipping and necessary supplies. They also describe clinician-selected supportive medication for side effects, if appropriate, with reassessment at a three-month follow-up. These are advertised inclusions, not a guarantee that every applicant receives the same prescription or additional medication.

The delivery timeline separates the stages: provider review can take up to two days, order processing up to five business days, then the advertised two-day shipping period. Free two-day shipping is not a promise that medication arrives two days after submitting an intake. For a damaged or temperature-sensitive delivery, contact the pharmacy or care team before deciding whether it is usable.

An approval promise and evaluation-fee clause do not agree

The product pages say no charge unless approved. The August 17 terms (opens in a new tab) say medical evaluation fees may be charged whether or not a prescription is issued unless otherwise stated, and may become nonrefundable once provider review starts. Those statements leave an important question: what exactly is the exception attached to your selected offer?

Before authorizing payment, ask whether a declined application costs anything, what the evaluation fee would be and when it becomes nonrefundable. Save the answer with the checkout terms. The terms identify the platform operator as LIVV Care LLC, doing business as 50 Stars Health; that name does not by itself identify your treating clinician or dispensing pharmacy.

Despite the name, GLP-1 access is not nationwide

The product FAQ lists forty-four states plus Puerto Rico. Alabama, Arkansas, California, Indiana, South Carolina and West Virginia are absent from that published state list; Washington, D.C. is not listed either. A general nationwide description on an About page should not override the treatment-specific restrictions.

The terms describe independent, state-licensed clinicians and pharmacies, while the treatment pages describe licensed partner pharmacies. Confirm who will prescribe, which pharmacy will dispense and whether that pharmacy can supply the selected formulation in your state. Our pharmacy verification guide gives you a practical starting point. Compounded preparations are not FDA-approved brand drugs, and the added vitamins do not establish an additional clinical benefit.

Cancellation does not normally return the paid balance

The return and refund policy (opens in a new tab) says subscriptions renew automatically, with the charge one day before each billing cycle begins. It asks patients to cancel at least two days before the next billing date through the portal. Renewal can continue even when actions needed to keep a prescription active have not been completed, so do not assume an unanswered follow-up automatically stops billing.

Cancellation takes effect at the end of the paid period. Refunds are not normally offered, although the company may allow a partial refund for an undispensed portion. Shipped prescription products cannot be returned or exchanged, even unopened. Replacement requests must be made within forty-eight hours and include packaging, vial and lot-number photographs plus an explanation. These are stated policy conditions, not a guarantee that a request will be approved.

The decision comes down to the commitment

The appeal is a published plan ladder that does not rise with the prescribed dose, with follow-up support and shipping included. The main reservations are the uncertain longer-plan charge schedule and the conflicting evaluation-fee wording. Clarify both before committing, and read the cancellation guide if getting out of a prepaid plan is a concern. This is a cash-pay service; its terms say it does not submit insurance claims on your behalf.

What stands out

  • Publishes monthly, three-month and six-month plan rates
  • Says prices stay the same across prescribed doses
  • Lists care, support, shipping and supplies as included

What to check

  • Longer-plan upfront charge and collection schedule need confirmation
  • Approval and evaluation-fee wording require clarification
  • Treatment-specific state list is narrower than nationwide marketing
  • Refunds are discretionary and replacement requests have a 48-hour deadline

Sources and review scope

Public information checked in November 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.